ProCE Banner Activity

Podcast Pearls
The Evolving Role of TKIs in First-line Treatment of Advanced HCC

Slideset Download
Summary slides for a podcast where Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss the evolving role of tyrosine kinase inhibitors in the first-line treatment of patients with advanced hepatocellular carcinoma.

Released: December 14, 2021



Supported by an educational grant from

Bayer Healthcare Pharma